Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, October 16 - Friday, October 20, 2023), and click each link to read and watch anything you may have missed.
1.) Gut microbiota associated with menopause symptoms
In a recent study, an association was found between the gut microbiota and menopause symptoms.
Click here for the full article.
2.) Prenatal telehealth use was low during early COVID-19
In a recent study, personal preference was the most common reason for people who gave birth not to use prenatal telehealth care.
Click here for the full article.
3.) Female cancer survivors have increased perceived infertility risk
In a recent study, an association was found between gastrointestional treatment type and perceived infertility risk.
Click here for the full article.
4.) Methods identified to reduce bleeding after cesarean delivery
Data has supported 2 novel methods of reducing postpartum hemorrhage risk after cesarean delivery, as discussed at the ANESTHESIOLOGY 2023 annual meeting.
Click here for the full article.
5.) AI effective at measuring blastocyst morphometric parameters
In a recent study, automatically measured blastocyst morphometrics found a correlation between blastocyst size and the odds of implantation.
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Similar delivery times between misoprostol dosages among obese patients reported
May 29th 2024A recent study found that obese patients undergoing induction of labor experienced similar delivery times regardless of whether they received 50 μg or 25 μg of vaginal misoprostol, though multiparous patients showed faster delivery with the higher dosage.
Read More
Major adverse pregnancy outcomes linked to long-term risk of kidney disease
May 28th 2024A recent study highlighted the significant association between adverse pregnancy outcomes and an elevated long-term risk of chronic kidney disease, emphasizing the need for heightened awareness and monitoring.
Read More